A Step-by-Step Guide to Selecting High-Quality Recombinant Proteins

Introduction

Recombinant proteins play a crucial role in cell therapy by providing essential growth factors, cytokines, and signaling molecules that regulate cell proliferation, differentiation, and survival. In cell therapy, recombinant proteins such as interleukins, growth factors, and stem cell factors support the maintenance and functional enhancement of therapeutic cells, ensuring their efficacy in clinical applications.

This guide provides a step-by-step approach in choosing the best recombinant proteins for your next research project.

1. Define your research objectives

Before selecting a recombinant protein, clearly define your research goals. Questions to consider before getting started:

• What level of purity and bioactivity is required?
• Are you studying a disease pathway, developing a drug, or testing a diagnostic tool?
• What specific biological function must the protein fulfill?

2. Choose the appropriate expression system

Recombinant protein expression systems are biological systems used to produce proteins by introducing a foreign gene (recombinant DNA) into a host organism. These systems enable the large-scale production of proteins for research and is widely used in biotechnology, pharmaceuticals (e.g., insulin, monoclonal antibodies), and vaccine development.

In determining which system to use, your lab should also consider the cell type that produces the protein, promoter, gene of interest, and an induction system to control timing and level of protein expression (like His-tag or GST-tag). The choice of expression system will also impact protein yield, structure, and functionality. Expression system options include:

• Bacterial (E. coli): High yield, fast, and cost-effective, but may lack proper post-translational modifications (PTMs).
• Yeast (Pichia pastoris, Saccharomyces cerevisiae): Suitable for eukaryotic proteins, improved PTMs, and scalability, yet sometimes leads to glycosylation.
• Mammalian (HEK293, CHO cells): Best for human-like PTMs and bioactivity, but more expensive.
• Insect (Sf9, Sf21, baculovirus system): Good for complex proteins with moderate PTMs.
• Plant-based and Cell-free Systems: Scalable, but complex and may lead to emerging technologies with unique advantages.

3. Assess protein purity and bioactivity

A protein’s purity and activity are crucial for reproducible results. Consider the following quality aspects:

• Purity Level: Confirm the percentage of pure protein (e.g., >95% for therapeutic studies).
• Endotoxin Levels: Low endotoxin content (<0.1 EU/µg) is essential for in vivo applications.
• Biological Activity: Verify using functional assays such as enzymatic activity, ligand binding, or cell-based assays.

4. Verify structural and functional integrity

Proper folding and structural integrity influence protein activity, consider the following:

• Post-Translational Modifications: Ensure necessary glycosylation, phosphorylation, or disulfide bonds are present.
• Protein Folding and Aggregation: Check for monomeric forms using SDS-PAGE, SEC-HPLC, or DLS.
• Stability and Storage: Evaluate the protein’s stability at different temperatures and buffer conditions.

5. Choose a supplier and source reliability

Choosing a reliable supplier is critical to the success of your research. In addition to quality, ensuring you have a primary and secondary supplier for your proteins early on, helps avoid problems later down the road. Other metrics to consider:

• Proof of Batch-to-Batch Consistency: Reliable sources provide consistent purity and activity levels.
• Verifying the Certificate of Analysis (CoA): Confirm specifications, testing results, and compliance with regulatory standards.
• Validating a Sample: You are the champion of your research, regardless of the supplier, always validate against your control to get expected results.

6. Review scalability and regulatory compliance

For therapeutic applications, ensure the recombinant protein meets clinical and regulatory standards of not only your region but consider other global regulatory requirements as well. Consider the following:

• Scalability: The expression system should support large-scale production without loss of quality.
• Ancillary Material: If progressing to clinical trials, the protein should be available as Research-grade and/or cGMP-grade proteins.
• Regulatory Approval: Confirm compatibility with FDA, EMA, PDMA, or other relevant regulatory guidelines.

7. Consider key systems today used in research

Cytokines, growth factors, and interleukins play a crucial role in stem cell research by regulating cell proliferation, differentiation, and maintenance. A fast way to choose starting material for your project is to look at some of the most popular proteins being used in stem cell research today. These include:

• Interleukin-7 (IL-7) – Plays a crucial role in the proliferation and differentiation of stem cells, particularly in hematopoiesis and immune regulation.
• Interleukin-15 (IL-15) – Supports the immune system and stimulates T cell, B cell, and NK cell activities..
• Stem Cell Factor (SCF) – Essential for hematopoietic stem cell survival, proliferation, and differentiation.
• Fibroblast Growth Factor-2 (FGF-2 or bFGF) – Promotes self-renewal and maintenance of pluripotency in embryonic and induced pluripotent stem cells.
• Transforming Growth Factor-Beta (TGF-β) – Regulates stem cell differentiation and plays a role in tissue homeostasis and immune modulation.

Summary

Selecting the right recombinant protein for therapeutic research involves careful consideration of expression system, purity, bioactivity, structure, supplier reliability, and regulatory factors. By following this guide, researchers can ensure the best protein choice for their specific application, ultimately leading to more effective and reliable therapeutic discoveries.

Learn More

• Learn more about Captivate Bio’s portfolio of Recombinant Proteins
• Learn more about Captivate Bio’s small molecules for stem cell research
• Research Spotlight: Efficient single-cell cloning of hPSCs using the CEPT cocktail
• Learn more about Cell Therapy Research Solutions from Captivate Bio